Global Orphan Drugs Market Research Report 2016

December 2016 | 111 pages | ID: G58E127ED7CEN
QYResearch

Abstracts

Notes:

Production, means the output of Orphan Drugs

Revenue, means the sales value of Orphan Drugs

This report studies Orphan Drugs in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering

• Bristol-Mayers Squibb
• Norartis
• Celgene
• Roche
• Pfizer
• Alexion
• Sanofi
• Vertes
• GSK
• Merck
• Johnson& Johnson

Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Orphan Drugs in these regions, from 2011 to 2021 (forecast), like

• North America
• Europe
• China
• Japan
• Southeast Asia
• India

Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into

• New molecular entities drugs
• Biologics drugs
• Other

Split by application, this report focuses on consumption, market share and growth rate of Orphan Drugs in each application, can be divided into

• Oncologic
• Metabolic
• Hematologic-immunologic
• Infections/ parasitic
• Other

Contents

Global Orphan Drugs Market Research Report 2016

1 ORPHAN DRUGS MARKET OVERVIEW

1.1 Product Overview and Scope of Orphan Drugs
1.2 Orphan Drugs Segment by Type
  1.2.1 Global Production Market Share of Orphan Drugs by Type in 2015
  1.2.2 New molecular entities drugs
  1.2.3 Biologics drugs
  1.2.4 Other
1.3 Orphan Drugs Segment by Application
  1.3.1 Orphan Drugs Consumption Market Share by Application in 2015
  1.3.2 Oncologic
  1.3.3 Metabolic
  1.3.4 Hematologic-immunologic
  1.3.5 Infections/ parasitic
  1.3.6 Other
1.4 Orphan Drugs Market by Region
  1.4.1 North America Status and Prospect (2011-2021)
  1.4.2 Europe Status and Prospect (2011-2021)
  1.4.3 China Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
  1.4.5 Southeast Asia Status and Prospect (2011-2021)
  1.4.6 India Status and Prospect (2011-2021)
1.5 Global Market Size (Value) of Orphan Drugs (2011-2021)

2 GLOBAL ORPHAN DRUGS MARKET COMPETITION BY MANUFACTURERS

2.1 Global Orphan Drugs Production and Share by Manufacturers (2015 and 2016)
2.2 Global Orphan Drugs Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global Orphan Drugs Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Orphan Drugs Manufacturing Base Distribution, Sales Area and Product Type
2.5 Orphan Drugs Market Competitive Situation and Trends
  2.5.1 Orphan Drugs Market Concentration Rate
  2.5.2 Orphan Drugs Market Share of Top 3 and Top 5 Manufacturers
  2.5.3 Mergers & Acquisitions, Expansion

3 GLOBAL ORPHAN DRUGS PRODUCTION, REVENUE (VALUE) BY REGION (2011-2016)

3.1 Global Orphan Drugs Production and Market Share by Region (2011-2016)
3.2 Global Orphan Drugs Revenue (Value) and Market Share by Region (2011-2016)
3.3 Global Orphan Drugs Production, Revenue, Price and Gross Margin (2011-2016)
3.4 North America Orphan Drugs Production, Revenue, Price and Gross Margin (2011-2016)
3.5 Europe Orphan Drugs Production, Revenue, Price and Gross Margin (2011-2016)
3.6 China Orphan Drugs Production, Revenue, Price and Gross Margin (2011-2016)
3.7 Japan Orphan Drugs Production, Revenue, Price and Gross Margin (2011-2016)
3.8 Southeast Asia Orphan Drugs Production, Revenue, Price and Gross Margin (2011-2016)
3.9 India Orphan Drugs Production, Revenue, Price and Gross Margin (2011-2016)

4 GLOBAL ORPHAN DRUGS SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGIONS (2011-2016)

4.1 Global Orphan Drugs Consumption by Regions (2011-2016)
4.2 North America Orphan Drugs Production, Consumption, Export, Import by Regions (2011-2016)
4.3 Europe Orphan Drugs Production, Consumption, Export, Import by Regions (2011-2016)
4.4 China Orphan Drugs Production, Consumption, Export, Import by Regions (2011-2016)
4.5 Japan Orphan Drugs Production, Consumption, Export, Import by Regions (2011-2016)
4.6 Southeast Asia Orphan Drugs Production, Consumption, Export, Import by Regions (2011-2016)
4.7 India Orphan Drugs Production, Consumption, Export, Import by Regions (2011-2016)

5 GLOBAL ORPHAN DRUGS PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 Global Orphan Drugs Production and Market Share by Type (2011-2016)
5.2 Global Orphan Drugs Revenue and Market Share by Type (2011-2016)
5.3 Global Orphan Drugs Price by Type (2011-2016)
5.4 Global Orphan Drugs Production Growth by Type (2011-2016)

6 GLOBAL ORPHAN DRUGS MARKET ANALYSIS BY APPLICATION

6.1 Global Orphan Drugs Consumption and Market Share by Application (2011-2016)
6.2 Global Orphan Drugs Consumption Growth Rate by Application (2011-2016)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

7 GLOBAL ORPHAN DRUGS MANUFACTURERS PROFILES/ANALYSIS

7.1 Bristol-Mayers Squibb
  7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.1.2 Orphan Drugs Product Type, Application and Specification
    7.1.2.1 Type I
    7.1.2.2 Type II
  7.1.3 Bristol-Mayers Squibb Orphan Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.1.4 Main Business/Business Overview
7.2 Norartis
  7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.2.2 Orphan Drugs Product Type, Application and Specification
    7.2.2.1 Type I
    7.2.2.2 Type II
  7.2.3 Norartis Orphan Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.2.4 Main Business/Business Overview
7.3 Celgene
  7.3.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.3.2 Orphan Drugs Product Type, Application and Specification
    7.3.2.1 Type I
    7.3.2.2 Type II
  7.3.3 Celgene Orphan Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.3.4 Main Business/Business Overview
7.4 Roche
  7.4.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.4.2 Orphan Drugs Product Type, Application and Specification
    7.4.2.1 Type I
    7.4.2.2 Type II
  7.4.3 Roche Orphan Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.4.4 Main Business/Business Overview
7.5 Pfizer
  7.5.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.5.2 Orphan Drugs Product Type, Application and Specification
    7.5.2.1 Type I
    7.5.2.2 Type II
  7.5.3 Pfizer Orphan Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.5.4 Main Business/Business Overview
7.6 Alexion
  7.6.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.6.2 Orphan Drugs Product Type, Application and Specification
    7.6.2.1 Type I
    7.6.2.2 Type II
  7.6.3 Alexion Orphan Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.6.4 Main Business/Business Overview
7.7 Sanofi
  7.7.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.7.2 Orphan Drugs Product Type, Application and Specification
    7.7.2.1 Type I
    7.7.2.2 Type II
  7.7.3 Sanofi Orphan Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.7.4 Main Business/Business Overview
7.8 Vertes
  7.8.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.8.2 Orphan Drugs Product Type, Application and Specification
    7.8.2.1 Type I
    7.8.2.2 Type II
  7.8.3 Vertes Orphan Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.8.4 Main Business/Business Overview
7.9 GSK
  7.9.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.9.2 Orphan Drugs Product Type, Application and Specification
    7.9.2.1 Type I
    7.9.2.2 Type II
  7.9.3 GSK Orphan Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.9.4 Main Business/Business Overview
7.10 Merck
  7.10.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.10.2 Orphan Drugs Product Type, Application and Specification
    7.10.2.1 Type I
    7.10.2.2 Type II
  7.10.3 Merck Orphan Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.10.4 Main Business/Business Overview
7.11 Johnson& Johnson

8 ORPHAN DRUGS MANUFACTURING COST ANALYSIS

8.1 Orphan Drugs Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Orphan Drugs

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Orphan Drugs Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Orphan Drugs Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL ORPHAN DRUGS MARKET FORECAST (2016-2021)

12.1 Global Orphan Drugs Production, Revenue Forecast (2016-2021)
12.2 Global Orphan Drugs Production, Consumption Forecast by Regions (2016-2021)
12.3 Global Orphan Drugs Production Forecast by Type (2016-2021)
12.4 Global Orphan Drugs Consumption Forecast by Application (2016-2021)
12.5 Orphan Drugs Price Forecast (2016-2021)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

Disclosure Section
Research Methodology
Data Source
China Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Orphan Drugs
Figure Global Production Market Share of Orphan Drugs by Type in 2015
Figure Product Picture of New molecular entities drugs
Table Major Manufacturers of New molecular entities drugs
Figure Product Picture of Biologics drugs
Table Major Manufacturers of Biologics drugs
Figure Product Picture of Other
Table Major Manufacturers of Other
Table Orphan Drugs Consumption Market Share by Application in 2015
Figure Oncologic Examples
Figure Metabolic Examples
Figure Hematologic-immunologic Examples
Figure Infections/ parasitic Examples
Figure Other Examples
Figure North America Orphan Drugs Revenue (Million USD) and Growth Rate (2011-2021)
Figure Europe Orphan Drugs Revenue (Million USD) and Growth Rate (2011-2021)
Figure China Orphan Drugs Revenue (Million USD) and Growth Rate (2011-2021)
Figure Japan Orphan Drugs Revenue (Million USD) and Growth Rate (2011-2021)
Figure Southeast Asia Orphan Drugs Revenue (Million USD) and Growth Rate (2011-2021)
Figure India Orphan Drugs Revenue (Million USD) and Growth Rate (2011-2021)
Figure Global Orphan Drugs Revenue (Million UDS) and Growth Rate (2011-2021)
Table Global Orphan Drugs Production of Key Manufacturers (2015 and 2016)
Table Global Orphan Drugs Production Share by Manufacturers (2015 and 2016)
Figure 2015 Orphan Drugs Production Share by Manufacturers
Figure 2016 Orphan Drugs Production Share by Manufacturers
Table Global Orphan Drugs Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global Orphan Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Orphan Drugs Revenue Share by Manufacturers
Table 2016 Global Orphan Drugs Revenue Share by Manufacturers
Table Global Market Orphan Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure Global Market Orphan Drugs Average Price of Key Manufacturers in 2015
Table Manufacturers Orphan Drugs Manufacturing Base Distribution and Sales Area
Table Manufacturers Orphan Drugs Product Type
Figure Orphan Drugs Market Share of Top 3 Manufacturers
Figure Orphan Drugs Market Share of Top 5 Manufacturers
Table Global Orphan Drugs Production by Regions (2011-2016)
Figure Global Orphan Drugs Production and Market Share by Regions (2011-2016)
Figure Global Orphan Drugs Production Market Share by Regions (2011-2016)
Figure 2015 Global Orphan Drugs Production Market Share by Regions
Table Global Orphan Drugs Revenue by Regions (2011-2016)
Table Global Orphan Drugs Revenue Market Share by Regions (2011-2016)
Table 2015 Global Orphan Drugs Revenue Market Share by Regions
Table Global Orphan Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Table North America Orphan Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Table Europe Orphan Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Table China Orphan Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Table Japan Orphan Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Table Southeast Asia Orphan Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Table India Orphan Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Table Global Orphan Drugs Consumption Market by Regions (2011-2016)
Table Global Orphan Drugs Consumption Market Share by Regions (2011-2016)
Figure Global Orphan Drugs Consumption Market Share by Regions (2011-2016)
Figure 2015 Global Orphan Drugs Consumption Market Share by Regions
Table North America Orphan Drugs Production, Consumption, Import & Export (2011-2016)
Table Europe Orphan Drugs Production, Consumption, Import & Export (2011-2016)
Table China Orphan Drugs Production, Consumption, Import & Export (2011-2016)
Table Japan Orphan Drugs Production, Consumption, Import & Export (2011-2016)
Table Southeast Asia Orphan Drugs Production, Consumption, Import & Export (2011-2016)
Table India Orphan Drugs Production, Consumption, Import & Export (2011-2016)
Table Global Orphan Drugs Production by Type (2011-2016)
Table Global Orphan Drugs Production Share by Type (2011-2016)
Figure Production Market Share of Orphan Drugs by Type (2011-2016)
Figure 2015 Production Market Share of Orphan Drugs by Type
Table Global Orphan Drugs Revenue by Type (2011-2016)
Table Global Orphan Drugs Revenue Share by Type (2011-2016)
Figure Production Revenue Share of Orphan Drugs by Type (2011-2016)
Figure 2015 Revenue Market Share of Orphan Drugs by Type
Table Global Orphan Drugs Price by Type (2011-2016)
Figure Global Orphan Drugs Production Growth by Type (2011-2016)
Table Global Orphan Drugs Consumption by Application (2011-2016)
Table Global Orphan Drugs Consumption Market Share by Application (2011-2016)
Figure Global Orphan Drugs Consumption Market Share by Application in 2015
Table Global Orphan Drugs Consumption Growth Rate by Application (2011-2016)
Figure Global Orphan Drugs Consumption Growth Rate by Application (2011-2016)
Table Bristol-Mayers Squibb Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bristol-Mayers Squibb Orphan Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Figure Bristol-Mayers Squibb Orphan Drugs Market Share (2011-2016)
Table Norartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Norartis Orphan Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Figure Norartis Orphan Drugs Market Share (2011-2016)
Table Celgene Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Celgene Orphan Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Figure Celgene Orphan Drugs Market Share (2011-2016)
Table Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Roche Orphan Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Figure Roche Orphan Drugs Market Share (2011-2016)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Orphan Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer Orphan Drugs Market Share (2011-2016)
Table Alexion Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Alexion Orphan Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Figure Alexion Orphan Drugs Market Share (2011-2016)
Table Sanofi Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi Orphan Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Figure Sanofi Orphan Drugs Market Share (2011-2016)
Table Vertes Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Vertes Orphan Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Figure Vertes Orphan Drugs Market Share (2011-2016)
Table GSK Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GSK Orphan Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Figure GSK Orphan Drugs Market Share (2011-2016)
Table Merck Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck Orphan Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Figure Merck Orphan Drugs Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Orphan Drugs
Figure Manufacturing Process Analysis of Orphan Drugs
Figure Orphan Drugs Industrial Chain Analysis
Table Raw Materials Sources of Orphan Drugs Major Manufacturers in 2015
Table Major Buyers of Orphan Drugs
Table Distributors/Traders List
Figure Global Orphan Drugs Production and Growth Rate Forecast (2016-2021)
Figure Global Orphan Drugs Revenue and Growth Rate Forecast (2016-2021)
Table Global Orphan Drugs Production Forecast by Regions (2016-2021)
Table Global Orphan Drugs Consumption Forecast by Regions (2016-2021)
Table Global Orphan Drugs Production Forecast by Type (2016-2021)
Table Global Orphan Drugs Consumption Forecast by Application (2016-2021)